Zydus Lifesciences receives USFDA approval for generic Eltrombopag tablets, treating thrombocytopenia (low platelet count).

A recent data analysis found a link between blood sugar spikes after meals and a higher risk of Alzheimer’s disease. Poorly ...

A generative AI system can now analyze blood cells with greater accuracy and confidence than human experts, detecting subtle signs of diseases like leukemia. It not only spots rare abnormalities but ...

The treatment for acquired thrombotic thrombocytopenic purpura, a rare blood disorder that causes blood clots in the small ...

Analyzing metabolites from routine blood draws could help doctors catch disease in early stages, then recommend preventative ...

As deforestation shrinks Brazil’s Atlantic Forest, mosquitoes that once fed on many animal species are increasingly turning ...

When eating, the body converts extra calories, especially from carbs, sugar, fats, and alcohol, into triglycerides.

Abu Dhabi successfully completes its first gene therapy for genetic blood disorders, revolutionizing treatment approaches for ...

Kavita Mehta is pinning her hopes on 2026 for a cure to a major blood disorder, following a breakthrough gene-editing ...

Scientists found that some mosquitoes really are targeting humans more than other food sources, but it could be a matter of ...

In the rapidly disappearing Atlantic Forest, mosquitoes are adapting to a human-dominated landscape. Scientists found that ...

Zydus Lifesciences has received final approval from the US Food and Drug Administration for its generic Eltrombopag tablets, strengthening its presence in the US generics market.